REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results